Iñigo Landa

6.3k total citations · 1 hit paper
46 papers, 3.0k citations indexed

About

Iñigo Landa is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Iñigo Landa has authored 46 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Iñigo Landa's work include Thyroid Cancer Diagnosis and Treatment (32 papers), BRCA gene mutations in cancer (13 papers) and Cancer-related Molecular Pathways (12 papers). Iñigo Landa is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (32 papers), BRCA gene mutations in cancer (13 papers) and Cancer-related Molecular Pathways (12 papers). Iñigo Landa collaborates with scholars based in United States, Spain and Italy. Iñigo Landa's co-authors include James A. Fagin, Ronald Ghossein, Ian Ganly, Tihana Ibrahimpašić, Jeffrey A. Knauf, Snjezana Doğan, Bin Xu, Mercedes Robledo, Gnana P. Krishnamoorthy and Luis J. Leandro‐García and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature reviews. Cancer.

In The Last Decade

Iñigo Landa

46 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

2016 862 citations Iñigo Landa, Tihana Ibrahimpašić et al. Journal of Clinical Investigation profile →

Peers

Iñigo Landa

EDM

ONCOL

GENET

Vasily Vasko United States

Todd G. Kroll United States

Joshua Klopper United States

Minjing Zou Saudi Arabia

Lin Pei United States

Vasyl Vasko United States

Aneeta Patel United States

Prashant Bavi Saudi Arabia

Akira Komiya Japan

Donata Vitagliano Italy

Vasily Vasko United States

Iñigo Landa

1.4k ×0.8

EDM

1.2k ×1.2

954 ×1.0

ONCOL

389 ×0.6

GENET

259 ×0.6

Citations per year, relative to Iñigo Landa Iñigo Landa (= 1×) peers Vasily Vasko

Countries citing papers authored by Iñigo Landa

Since Specialization

Citations

This map shows the geographic impact of Iñigo Landa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iñigo Landa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iñigo Landa more than expected).

Fields of papers citing papers by Iñigo Landa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iñigo Landa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iñigo Landa. The network helps show where Iñigo Landa may publish in the future.

Co-authorship network of co-authors of Iñigo Landa

This figure shows the co-authorship network connecting the top 25 collaborators of Iñigo Landa. A scholar is included among the top collaborators of Iñigo Landa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iñigo Landa. Iñigo Landa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bikas, Athanasios, Θεοδώρα Παππά, Ellen Marqusee, et al.. (2024). Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 109(8). 1996–2002. 2 indexed citations

Bikas, Athanasios, Sara Ahmadi, Θεοδώρα Παππά, et al.. (2023). Additional Oncogenic Alterations in RAS -Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes. Clinical Cancer Research. 29(14). 2678–2685. 16 indexed citations

Landa, Iñigo, Bin Xu, Jacob Haase, et al.. (2023). Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects. Molecular Cancer Research. 21(11). 1163–1175. 12 indexed citations

Ahmadi, Sara & Iñigo Landa. (2023). The prognostic power of gene mutations in thyroid cancer. Endocrine Connections. 13(2). 6 indexed citations

Landa, Iñigo & Maria E. Cabanillas. (2023). Genomic alterations in thyroid cancer: biological and clinical insights. Nature Reviews Endocrinology. 20(2). 93–110. 52 indexed citations

Παππά, Θεοδώρα, Sara Ahmadi, Ellen Marqusee, et al.. (2021). Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients. Clinical Cancer Research. 27(15). 4256–4264. 33 indexed citations

Xu, Bin, Talia L. Fuchs, Snjezana Doğan, et al.. (2020). Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases. Thyroid. 30(10). 1505–1517. 177 indexed citations

Landa, Iñigo, Nikita Pozdeyev, Christopher Korch, et al.. (2019). Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clinical Cancer Research. 25(10). 3141–3151. 130 indexed citations

Schweppe, Rebecca E., Nikita Pozdeyev, Laura A. Pike, et al.. (2019). Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers. Molecular Cancer Research. 17(5). 1036–1048. 12 indexed citations

10.

Fletcher, Alice, Martin L. Read, Dean P. Larner, et al.. (2019). Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake. Cancer Research. 80(1). 102–115. 34 indexed citations

11.

Krishnamoorthy, Gnana P., Natalie R. Davidson, Steven D. Leach, et al.. (2018). EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC. Cancer Discovery. 9(2). 264–281. 71 indexed citations

12.

Ibrahimpašić, Tihana, Bin Xu, Iñigo Landa, et al.. (2017). Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clinical Cancer Research. 23(19). 5970–5980. 94 indexed citations

13.

Landa, Iñigo, Tihana Ibrahimpašić, Laura Boucai, et al.. (2016). Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. Journal of Clinical Investigation. 126(3). 1052–1066. 862 indexed citations breakdown →

14.

García-Rendueles, María E.R., Julio C. Ricarte‐Filho, Brian R. Untch, et al.. (2015). NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. Cancer Discovery. 5(11). 1178–1193. 99 indexed citations

15.

Landa, Iñigo, Ian Ganly, Timothy A. Chan, et al.. (2013). Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease. The Journal of Clinical Endocrinology & Metabolism. 98(9). E1562–E1566. 337 indexed citations

16.

Leandro‐García, Luis J., Susanna Leskelä, Lucía Inglada‐Pérez, et al.. (2012). Hematologic β-Tubulin VI Isoform Exhibits Genetic Variability That Influences Paclitaxel Toxicity. Cancer Research. 72(18). 4744–4752. 21 indexed citations

17.

Cascón, Alberto, Luis J. Leandro‐García, Rocío Letón, et al.. (2011). Detection of the first gross CDC73 germline deletion in an HPT‐JT syndrome family. Genes Chromosomes and Cancer. 50(11). 922–929. 37 indexed citations

18.

Landa, Iñigo, Cristina Montero‐Conde, Donatella Malanga, et al.. (2010). Allelic variant at −79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels. Endocrine Related Cancer. 17(2). 317–328. 25 indexed citations

19.

Rodríguez‐Antona, Cristina, Cristina Montero‐Conde, Lucía Inglada‐Pérez, et al.. (2009). Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis. Endocrine Related Cancer. 17(1). 7–16. 106 indexed citations

20.

López‐Jiménez, Elena, José M. de Campos, Iñigo Landa, et al.. (2008). SDHC mutation in an elderly patient without familial antecedents. Clinical Endocrinology. 69(6). 906–910. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact